Kaul I, Sawchak S, Correll C U, et al. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial[J]. The Lancet, 2023. https://...
Kaul I, Sawchak S, Correll C U, et al. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial[J]. TheLancet, 2023. https://ww...
Gaining trust through transparency: the EMERGENT-2 trialdoi:10.1016/S0140-6736(24)01268-6Matthew J LennonGin S MalhiElsevier LtdThe Lancet
新技术、新靶点药物的早期临床研究与注册性临床研究(Pivotal Trial)的价值在整个药物研发中日益显著。其中,试验结果对于适应症拓展与后续研究的方案制定具有举足轻重的作用,因而对结果的解读很有必要。 医药魔方NextPharma & TrialCube数据库围绕行业现状及未来趋势,将早期临床研究与注册性临床研究的结果进行筛选,并对其中...
Synonyms for emergent in Free Thesaurus. Antonyms for emergent. 19 synonyms for emergent: developing, coming, beginning, rising, appearing, budding, burgeoning, fledgling, nascent, incipient, burning, crying, dire, exigent. What are synonyms for emergent
“Karuna will continue to gather data through our EMERGENT clinical trial program to understand how KarXT’s novel mechanism of action could meaningfully bridge current treatment gaps for patients and their care partners.” Details ...
looperprovides a fully step-able hierarchical looping control framework (e.g., Run / Epoch / Trial / Cycle) where you can insert functions to run at different points (start, end, or specific counter value).Axonuses this natively and has support functions for configuring standard looper function...
) trial which showed that the hospital mortality for surgical repair of VSR with patients in cardiogenic shock was 81%.28 Surgical Repair of post-infarction ventricular septal rupture: Determinants of operative mortality and survival outcome analysis Gastrointestinal variceal bleeding is a frequently ...
Got it. That's really helpful. And I guess pivoting toward mpox, just curious if the MOSA trial is still on track for its first interim analysis during the end of this first quarter. Joe Papa--President and Chief Executive Officer
EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРусскийTürkçeאנגלית 9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook ...